New crown vaccination can reduce the risk of severe illness and death by 90%

According to French media reports, a large-scale study involving about 22 million people showed that vaccination of the new crown vaccine can reduce the risk of hospitalization and death by 90% for people over 50 years old, and the vaccine is also effective against Delta variants

The scientific research team "Epi-Phare" (Epi-Phare), composed of the French Medical Insurance Agency and the French National Drug Safety Administration, released the latest research results

The head of Epidemiology Beacon and epidemiologist Mahmoud Zrik said: “The risk of vaccinated people being hospitalized or dying from new coronary pneumonia is 1/9 of those of unvaccinated people

Since the Delta variant is currently the most popular variant of the new coronavirus, researchers have made a special assessment of the vaccine effect during the widespread spread of the Delta variant

Research leader Zrik pointed out that although preliminary information is provided on the protective effect of the vaccine on the Delta variant, "the research phase is too short to assess the true effect of the vaccine on this variant strain

The new crown vaccines involved in the research include Pfizer, Modena, and Oxford/AstraZeneca vaccines.